SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness

SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, could offer protective immunity, and may affect clinical outcomes of COVID-19 patients. We analyzed 625 serial plasma samples...

詳細記述

保存先:
書誌詳細
出版年:medRxiv
主要な著者: Röltgen, Katharina, Wirz, Oliver F., Stevens, Bryan A., Powell, Abigail E., Hogan, Catherine A., Najeeb, Javaria, Hunter, Molly, Sahoo, Malaya K., Huang, ChunHong, Yamamoto, Fumiko, Manalac, Justin, Otrelo-Cardoso, Ana R., Pham, Tho D., Rustagi, Arjun, Rogers, Angela J., Shah, Nigam H., Blish, Catherine A., Cochran, Jennifer R., Nadeau, Kari C., Jardetzky, Theodore S., Zehnder, James L., Wang, Taia T., Kim, Peter S., Gombar, Saurabh, Tibshirani, Robert, Pinsky, Benjamin A., Boyd, Scott D.
フォーマット: Artigo
言語:Inglês
出版事項: Cold Spring Harbor Laboratory 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444305/
https://ncbi.nlm.nih.gov/pubmed/32839786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.15.20175794
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料